Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
α-glucosyl hesperidin is a modified form of the citrus flavonoid hesperidin, produced by enzymatically attaching an α-glucosyl group to the parent molecule. This modification dramatically increases its water solubility (by up to 10,000-fold) and bioavailability compared to native hesperidin[5][6][8]. As a result, α-glucosyl hesperidin exhibits enhanced antioxidant and anti-inflammatory properties. It is explored for potential therapeutic effects in cardiovascular health, type II diabetes, obesity prevention (notably in combination with green tea), wound healing, UV protection, and skin health[1][5][6][8]. The compound is used as an ingredient in functional foods and beverages for its health benefits; it also appears in cosmetics for skin hydration and anti-aging purposes. In pharmaceuticals and dietary supplements, it is valued for its neuroprotective effects and ability to support immune function[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on α-glucosyl hesperidin.